NO20073213L - Fremgangsmate for fremstilling av tiofenglykosidderivater - Google Patents

Fremgangsmate for fremstilling av tiofenglykosidderivater

Info

Publication number
NO20073213L
NO20073213L NO20073213A NO20073213A NO20073213L NO 20073213 L NO20073213 L NO 20073213L NO 20073213 A NO20073213 A NO 20073213A NO 20073213 A NO20073213 A NO 20073213A NO 20073213 L NO20073213 L NO 20073213L
Authority
NO
Norway
Prior art keywords
preparation
glycoside derivatives
thiophene
thiophene glycoside
aryl
Prior art date
Application number
NO20073213A
Other languages
English (en)
Inventor
Volker Derdau
Lars Bierer
Michael Kossenjans
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of NO20073213L publication Critical patent/NO20073213L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Det beskrives en fremgangsmåte for fremstilling av tiofenglykosidderivater med den generelle formel (I), der: Y er hydrogen eller alkyl; R1 er alkyl, hvorved hydrogenene kan være substituert med fluor eller aryl, og aryl også kan inneholde heteroatomer; og R2 er hydrogen, Cl, Br eller 1.
NO20073213A 2004-12-22 2007-06-22 Fremgangsmate for fremstilling av tiofenglykosidderivater NO20073213L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004063099A DE102004063099B4 (de) 2004-12-22 2004-12-22 Verfahren zur Herstellung von Thiophenglycosidderivaten
PCT/EP2005/013158 WO2006072334A2 (de) 2004-12-22 2005-12-08 Verfahren zur herstellung von thiophenglycosidderivaten

Publications (1)

Publication Number Publication Date
NO20073213L true NO20073213L (no) 2007-09-19

Family

ID=36599271

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20073213A NO20073213L (no) 2004-12-22 2007-06-22 Fremgangsmate for fremstilling av tiofenglykosidderivater

Country Status (29)

Country Link
US (1) US20080207882A1 (no)
EP (1) EP1888613B1 (no)
JP (1) JP2008524272A (no)
KR (1) KR20070089946A (no)
CN (1) CN101080416A (no)
AR (1) AR052272A1 (no)
AT (1) ATE415407T1 (no)
AU (1) AU2005324187A1 (no)
BR (1) BRPI0519438A2 (no)
CA (1) CA2591114A1 (no)
CL (1) CL2008002563A1 (no)
CY (1) CY1108819T1 (no)
DE (2) DE102004063099B4 (no)
DK (1) DK1888613T3 (no)
ES (1) ES2318574T3 (no)
HR (1) HRP20090105T3 (no)
IL (1) IL183806A0 (no)
MA (1) MA29111B1 (no)
NO (1) NO20073213L (no)
NZ (1) NZ555591A (no)
PL (1) PL1888613T3 (no)
PT (1) PT1888613E (no)
RS (1) RS50726B (no)
RU (1) RU2394835C2 (no)
SI (1) SI1888613T1 (no)
TW (1) TW200635940A (no)
UY (1) UY29306A1 (no)
WO (1) WO2006072334A2 (no)
ZA (1) ZA200704028B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2008002427A1 (es) 2007-08-16 2009-09-11 Boehringer Ingelheim Int Composicion farmaceutica que comprende 1-cloro-4-(b-d-glucopiranos-1-il)-2-[4-((s)-tetrahidrofurano-3-iloxi)bencil]-benceno combinado con 1-[(4-metilquinazolin-2-il)metil]-3-metil-7-(2-butin-1-il)-8-(3-(r)-aminopiperidin-1-il)xantina; y su uso para tratar diabetes mellitus tipo 2.
CN104906582A (zh) 2009-02-13 2015-09-16 勃林格殷格翰国际有限公司 包含sglt2抑制剂、dpp-iv抑制剂和任选的另一种抗糖尿病药的药物组合物及其用途
AR085689A1 (es) 2011-03-07 2013-10-23 Boehringer Ingelheim Int Composiciones farmaceuticas de metformina, linagliptina y un inhibidor de sglt-2
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10231370B4 (de) * 2002-07-11 2006-04-06 Sanofi-Aventis Deutschland Gmbh Thiophenglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel

Also Published As

Publication number Publication date
IL183806A0 (en) 2007-10-31
CY1108819T1 (el) 2014-04-09
UY29306A1 (es) 2006-07-31
EP1888613B1 (de) 2008-11-26
DE502005006107D1 (de) 2009-01-08
ZA200704028B (en) 2008-08-27
TW200635940A (en) 2006-10-16
ATE415407T1 (de) 2008-12-15
KR20070089946A (ko) 2007-09-04
HRP20090105T3 (en) 2009-03-31
PT1888613E (pt) 2009-01-30
RS50726B (sr) 2010-08-31
ES2318574T3 (es) 2009-05-01
CN101080416A (zh) 2007-11-28
AU2005324187A1 (en) 2006-07-13
EP1888613A2 (de) 2008-02-20
NZ555591A (en) 2009-07-31
WO2006072334A3 (de) 2007-06-07
CL2008002563A1 (es) 2009-01-02
DE102004063099B4 (de) 2009-02-12
WO2006072334A2 (de) 2006-07-13
AR052272A1 (es) 2007-03-07
US20080207882A1 (en) 2008-08-28
BRPI0519438A2 (pt) 2009-01-20
RU2007127840A (ru) 2009-01-27
CA2591114A1 (en) 2006-07-13
SI1888613T1 (sl) 2009-04-30
MA29111B1 (fr) 2007-12-03
PL1888613T3 (pl) 2009-04-30
DE102004063099A1 (de) 2006-07-13
RU2394835C2 (ru) 2010-07-20
JP2008524272A (ja) 2008-07-10
DK1888613T3 (da) 2009-03-30

Similar Documents

Publication Publication Date Title
MY142807A (en) Benzimidazole derivative and use thereof.
DK0944617T3 (da) Krystaller af benzimidazolderivater og deres fremstilling
NO20064669L (no) Dipeptidylpeptidaseinhibitorer
CY1116885T1 (el) Υποκατεστημενα παραγωγα κυκλοεξυλομεθυλιου
NO20092770L (no) Nye aminopyrimidinderivater som PLK1-inhibitorer
NO20080157L (no) Fremgangsmate for syntese av organiske forbindelser
WO2008136444A1 (ja) 縮合複素環誘導体
NO20054852L (no) GFAT inhibitorer
NO20050418L (no) Kondenserte pyridiner og pyrimidiner med TIE2(TEK) aktivitet
NO20071642L (no) N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger
NO20053890L (no) Syntese av 4-amino-2-butenolklorider og anvendelse derav for fremstilling av 3-cyanokinoliner
NO20082116L (no) Kjemisk fremgangsmate for fremstilling av en amido-fenoksybenzosyreforbindelse
NO20072753L (no) 3-Etylidenhydrazinosubstituerte heterocykliske forbindelser som trombopoietinreseptoraktivatorer
NO20062936L (no) Fremgangsmate for fremstilling av N-alkyl-2(hydroksy-4-benzoyl)-3-benzofuraner og dets mellomprodukter derav
NO20082226L (no) 6-heteroarylpyridoindolonderivater, deres fremstilling og terapeutisk anvendelse derav
NO20073213L (no) Fremgangsmate for fremstilling av tiofenglykosidderivater
ATE488510T1 (de) Heterocyclische derivate, deren herstellung und therapeutische verwendung
NO20063111L (no) Fremgangsmate for fremstilling av tiazolpyrimidiner
EA200700767A1 (ru) Способ получения пиразолов
EA200700179A1 (ru) Производные пиррола, их получение и их применение в терапии
NO20062307L (no) Spirofuropyridinarylderivater
GB0003257D0 (en) Heterocyclic compounds and their therapeutic use
TNSN06337A1 (en) 6-substituted pyridoindolone derivatives production and therapeutic use thereof
NO20055991L (no) Fremgangsmate for syntetisering av heterocykliske forbindelser
EA201070818A1 (ru) ПРОИЗВОДНЫЕ N-ГЕТЕРОЦИКЛИЧЕСКИХ-6-ГЕТЕРОЦИКЛИЧЕСКИХ-ИМИДАЗО[1,2a]ПИРИДИН-2-КАРБОКСАМИДОВ, ИХ ПОЛУЧЕНИЕ И ИХ ПРИМЕНЕНИЕ В ТЕРАПИИ

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application